Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children's Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006. Since 2007, he is the Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.
Dr. de Val is currently working as the Director of the Electron Microscopy Laboratory and as the Team Lead of the Cryo-EM section at the Center for Molecular Microscopy, both laboratories located at the Frederick National Laboratory for Cancer Research, in Frederick, Maryland, USA. De Val completed her Masters in Biochemistry from the University of Zaragoza, Spain. She received her Doctoral degree in Biochemistry from the University of Leuven, Belgium. She then did postdoctoral work at UC-Berkeley (CA, USA) and the Pasteur Institute (Paris, France). From 2012-2016, she played a key role in ground-breaking studies at the Scripps Research Institute in La Jolla (CA, USA) defining the structure of the HIV-1 envelope glycoprotein complex bound to neutralizing antibodies. This work used cryo-EM to provide important insights into HIV-1 envelope glycoprotein. During this time, she also contributed to structural analysis of the Ebola virus glycoprotein. Before relocating from California to Frederick, Dr. de Val served as Principal Scientist at NanoImaging Services Inc., where she led cryo-EM studies for numerous clients, including pharmaceutical companies. De Val has authored more than 30 publications in prestigious journals. Her publications reflect her research interests in Structural Biology, mainly focusing on single particle cryo-EM.
Professor S. Louise Cosby (SLC) was appointed as Head of Virology Branch at the Agri-Food and Biosciences institute, UK, in 2015. She was Chair of Microbiology in Queen's University Belfast from 2002 and remains an emeritus Professor in the university. SLC is a Fellow of Royal College of Pathologists (London) and Fellow of the Royal Society of Biology, UK. She has served/currently serves on grant/editorial boards: BBSRC, UK; Chair/member, Science Foundation Ireland; British Society for Immunology Forum, Professional Development Committee, Microbiology Society, UK; Associate Editor, Journal of Neurovirology, USA; Review editor, Frontiers in Microbiology.
Dr. Jackson is Professor of Medicine (Neurology) and of Medical Microbiology at University of Manitoba in Winnipeg, Manitoba, Canada. He graduated from Queen's University with BA (magna cum laude) and MD degrees. He completed residencies in internal medicine at Queen's University and in neurology at University of Western Ontario and a fellowship in neurovirology at The Johns Hopkins University. Dr. Jackson held a faculty position at Queen's University from 1987 - 2007. He was the first President of Rabies in the Americas, Inc. and he has served on the Board of Directors of the International Society for Neurovirology from 2000-2018.
Professor Piotr Heczko - Head of the Institute of Microbiology of the Jagiellonian University Medical College, Krakow, Poland. President of the Polish Association of Hospital Infections (PTZS) in Krakow, Member of the Committee of Immunology and Ethiology of Human Infections of the Polish Academy of Sciences.
Michel Federighi is professor in food safety and hygien at the National Veterinary School of Nantes (France) specialized in zoonotic agents since 25 years. He is also expert for the french agency of food safety (Anses) and vice-president of the French Society of Microbiology (SFM)
Dr. Kenneth Yongabi Anchang is an academic as well as the research expert / scientific anchor of STK Biotech Ltd. Dr. Kenneth Yongabi Anchang is an Associate Professor, with a PhD and D.Sc in Public Health Infectiology (ATBU/USA) and a PhD in Biochemical Engineering (Australia). He received his undergraduate and part of his Post graduate studies at Abubakar Tafawa Balewa University in Nigeria, where he also lectured for five years. Dr. Kenneth is also a practicing Naturopath doctor and member of the American Naturopathic Medical Association. His medical science practice has been highly focused on a holistic integrative medicine with particular attention on African indigenous medical approach. He lectures on naturopathic medicine, public health engineering and clinical microbiology and Biotechnology in many local and international institutions and is a faculty member at the Catholic University of Cameroon in Bamenda, where he doubles as Director of Research. He has a strong background in the development of sustainable biotechnologies with the application of natural products for treatment of tropical diseases.